This presentation was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Sanchez's presentation recording and slides below. Presentation Recording: Presentation Slides:
In the recent publication, Partial-Brain Radiation-Induced Microvascular Cognitive Impairment in Juvenile Murine Unilateral Hippocampal Synaptic Plasticity, researchers used partial-brain radiation therapy to evaluate strategies to reduce cognitive decline in...
In the recent publication, Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy, researchers examined treatment modalities to aid the development of PARP inhibitors. These compounds target tumors deficient in the Homologous Recombination...
This presentation on imaging of benign fibromatoses was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Wolfson's presentation recording and slides below. Presentation Recording: Presentation Slides:
Changes in cancer care are driving a demand for improved outcomes at greater efficiency and reduced costs. In this presentation, Dr. Julya Zuenkova describes a value-based approach in radiotherapy to use X-rays for operational efficacy. Learn how these treatments...
This presentation on the Multicenter Patterns of Care Study was part of the 2021 clinical symposia, Radiotherapy for Benign Conditions. See Dr. Micke's presentation recording and slides below. Presentation Recording: Presentation Slides:
In the study, Differential Effects of Radiation Fractionation Regimens on Glioblastoma, researchers compared radiation regimens for glioblastomas, and their radiotoxicity and neurocognitive effects. SARRP was used for in vivo and in vitro irradiation in the study. See...
We are thrilled to announce that MuriSuite, a brand new control system for all SARRP devices, will be released this year. Hear more in this video from our CEO, Adrian Treverton and our resident SARRP expert, Wilfried Goetz. https://vimeo.com/710478777
ΠΠ΅Π±ΠΈΠ½Π°Ρ Π²Π΅Π΄Π΅Ρ ΠΏΡΠΎΡΠ΅ΡΡΠΎΡ ΠΠ³Π°Π²Π° (Π―ΠΏΠΎΠ½ΠΈΡ). ΠΡ ΡΠ·Π½Π°Π΅ΡΠ΅ ΠΎ ΡΠΎΠ²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΡΠΏΠΎΡΠΎΠ±Π°Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΊΠ΅Π»Π»ΠΎΠΈΠ΄Π½ΡΡ ΡΡΠ±ΡΠΎΠ², Π½ΠΎΠ²Π΅ΠΉΡΠΈΡ ΡΡ Π΅ΠΌΠ°Ρ Π»ΡΡΠ΅Π²ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΈ ΡΠ΅Π°Π±ΠΈΠ»ΠΈΡΠ°ΡΠΈΠΈ ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ. Π Π΅ΠΉ ΠΠ³Π°Π²Π° - ΠΏΡΠΎΡΠ΅ΡΡΠΎΡ ΠΈ Π·Π°Π²Π΅Π΄ΡΡΡΠΈΠΉ ΠΊΠ°ΡΠ΅Π΄ΡΠΎΠΉ ΠΏΠ»Π°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΈ ΡΡΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Ρ ΠΈΡΡΡΠ³ΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΠΈΡΡ...
Contact Us